Navigation Links
Detecting 'bath salts' designer drug

HUNTSVILLE, TX -- In October 2011 the National Institute of Justice (NIJ) and the Forensic Science Foundation (FSF) funded a capstone project proposal in the Master of Forensic Science Program at Sam Houston State University to investigate the designer drugs known as "Bath Salts" (beta-keto-amphetamines or BKAs).

Designer drugs have posed a challenge for law enforcement and forensic scientists for decades, but more recently the proliferation of analogs has overwhelmed the scientific community, in large part due to the internet. The majority of BKA designer drugs are derived from cathinone, the active ingredient of Khat (Catha edulis), a plant native to Africa and the Middle East. Synthesis of these drugs is readily accomplished by clandestine chemists, making it an appealing drug for the designer drugs market.

The study will specifically address a number of central nervous system stimulants that are capable of producing powerful and unpredictable adrenergic and hallucinogenic effects. Many of these drugs were considered "legal highs" until the Drug Enforcement Administration placed several of them in Schedule I of the Federal Controlled Substance Act in an emergency scheduling action earlier this year. These drugs were available locally in gas stations, head shops and online until September 1 of this year, when The State of Texas enacted legislation to ban these substances. At least 24 other states have outlawed them, or have legislation pending due to intense media interest and publicity.

In the SHSU study, at least six of the most popular "bath salt" drugs will be investigated in biological samples. These include mephedrone, methylone, ethylone, butylone, MDPV and naphyrone. Mephedrone is one of the most common BKAs. It has a reputation of having similar but superior effects to MDMA (3,4 -methylenedioxymethamphetamine or Ecstasy). Street names for mephedrone include MCAT, meow meow, MMC hammer, 4 MMC, bubbles, meph, rush, drone and plant feeder. Mephedrone and the related BKAs are still relatively new, so few clinical, pharmacological or toxicological studies have been reported.

These drugs are easily identified in seized drug materials. The SHSU Regional Crime Laboratory (RCL), operated by the Criminal Justice Center, routinely receives items of evidence containing these drugs. Detection in toxicological (biological) evidence is far more challenging. Toxicologists are struggling to develop methodology to detect these drugs (and their metabolites) in biological specimens. Even less is understood with respect to the interpretation of results, and this has real consequences in terms of criminal casework and death investigation.

In order for these drugs to be studied and understood, analytical methodology will be developed for routine use. In the study, solid phase extraction (SPE) will be used to isolate the beta-keto amphetamines from biological matrices. Chromatographic and spectroscopic methods will be developed for instrumental analysis of the biological extracts. Chemical derivatization will be used to develop extracts that are amenable to common instrumental techniques that are used in a crime laboratory, such as gas chromatography/mass spectrometry (GC/MS).

The study, which will be conducted by MSFS student Kayla Ellefsen and Dr. Sarah Kerrigan at RCL, is an example of the MSFS student capstone experience, whereby students must successfully complete an intensive one-year research project with a faculty member. During the final phase of the study, the optimized procedure will be validated for use in actual casework at the lab.


Contact: Beth Kuhles
Sam Houston State University

Related medicine news :

1. Study: Mechanomyography to be accurate in detecting nerves during minimally invasive spine surgery
2. FDG-PET/CT plays a definite role in detecting colorectal cancer recurrences
3. Detecting tumors faster
4. Sodium MRI gives new insights into detecting osteoarthritis, NYU researchers find
5. Effective methods for detecting early signs of tremor
6. Colorful brains, cooling lasers, disease-detecting lights and more
7. deCODE discovers genetic markers that improve the power of PSA testing for detecting prostate cancer
8. Detecting esophageal cancer with light
9. New molecular imaging technologies for detecting cellular processes
10. Toward a fast, simple test for detecting cholera rampaging in 40 countries
11. Penn study suggests another avenue for detecting Alzheimers disease
Post Your Comments:
(Date:12/1/2015)... , ... December 01, 2015 , ... ... radiographic technicians must mark the film for accurate interpretation by the radiologist. The ... Fortunately, an inventor from Sacramento, Calif., has found a way to alleviate this ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... (BHCOE) today announced that the organization has awarded Education and Developmental Therapies (EDT), ... Distinguished Award. The award celebrates exceptional special needs providers that excel in synthesizing ...
(Date:12/1/2015)... , ... December 01, 2015 , ... Lutronic, a leading ... Clarity, the latest addition to the devices for sale in the United States. ... Alexandrite and long-pulsed 1064 nm Nd:YAG lasers, into a single platform that is easy ...
(Date:12/1/2015)... ... December 01, 2015 , ... XTC Semifinals 2016 ... semi-finalists to head to Las Vegas for CES 2016, the world’s largest Consumer Electronic ... Consumer Technology Association Gary Shapiro, Founding Partner of Pacific Investments Veronica Serra, and venture ...
(Date:12/1/2015)... , ... December 01, 2015 , ... Nurotron Biotechnology Co., ... its largest order to date. , The order will be from the China ... Venus Cochlear Implant System is an effective solution for children and adults suffering from ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... , Dec. 1, 2015  Athletic apparel ... founder have agreed to pay $1.35 million to ... advertised the company,s copper-infused compression clothing would relieve ... arthritis and other diseases. Tommie ... requires the company and its founder and chairman ...
(Date:12/1/2015)... , Dec. 1, 2015 Assurex Health, ... GeneSight® Psychotropic test giving healthcare providers an expanded range ... for patients suffering from depression, anxiety, bipolar disorder, ... health conditions. i .   ... With the addition of two new drug ...
(Date:12/1/2015)... Calif. , Dec. 1, 2015 ... products and services, announced today that it has been ... services organization. Members served by Novation will have access ... devices, sports bracing products and soft goods dedicated to ... --> The aging U.S. population, rising prevalence ...
Breaking Medicine Technology: